Phage-displayed mimotopes recognizing a biologically active anti-HIV-1 gp120 murine monoclonal antibody. 2002

Victor Raul Gómez-Román, and Chuanhai Cao, and Yun Bai, and Hugo Santamaría, and Gonzalo Acero, and Karen Manoutcharian, and David B Weiner, and Kenneth E Ugen, and Goar Gevorkian
Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, DF.

Antibody-dependent cellular cytotoxicity (ADCC) is a host defense mechanism in which Fc receptor-bearing effector cells in combination with antigen-specific antibodies recognize and kill antigen-expressing target cells. The authors previously described a murine monoclonal antibody (MAb-ID6) that mediated ADCC activity against HIV-infected cells. It was demonstrated that the specificity of MAb-ID6 maps to the first 204 amino acids of gp120; however, the exact epitope was not identified. In the present work, by screening phage display libraries with MAb-ID6, the authors have mapped the corresponding epitope to amino acids 86-100 (HIV-1 gp120 sequence). This epitope lies within the C1 region of gp120 and is highly conserved among all subtypes and circulating recombinant forms of HIV-1. Thus, these phage mimotopes of C1 may serve as components of a vaccine for the induction of gp120-specific antibodies mimicking MAb-ID6.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000920 Antibody-Dependent Cell Cytotoxicity The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. ADCC,Cytotoxicity, Antibody-Dependent Cell,Cell Cytoxicity, Antibody-Dependent,Antibody Dependent Cell Cytotoxicity,Antibody-Dependent Cell Cytotoxicities,Antibody-Dependent Cell Cytoxicities,Antibody-Dependent Cell Cytoxicity,Cell Cytotoxicities, Antibody-Dependent,Cell Cytotoxicity, Antibody-Dependent,Cell Cytoxicities, Antibody-Dependent,Cell Cytoxicity, Antibody Dependent,Cytotoxicities, Antibody-Dependent Cell,Cytotoxicity, Antibody Dependent Cell,Cytoxicities, Antibody-Dependent Cell,Cytoxicity, Antibody-Dependent Cell
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D001435 Bacteriophages Viruses whose hosts are bacterial cells. Phages,Bacteriophage,Phage
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015699 HIV Envelope Protein gp120 External envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 120 kDa and contains numerous glycosylation sites. Gp120 binds to cells expressing CD4 cell-surface antigens, most notably T4-lymphocytes and monocytes/macrophages. Gp120 has been shown to interfere with the normal function of CD4 and is at least partly responsible for the cytopathic effect of HIV. Envelope Glycoprotein gp120, HIV,HTLV-III gp120,env Protein gp120, HIV,gp120(HIV),HIV Envelope Glycoprotein gp120,gp120 Envelope Glycoprotein, HIV,HTLV III gp120,gp120, HTLV-III

Related Publications

Victor Raul Gómez-Román, and Chuanhai Cao, and Yun Bai, and Hugo Santamaría, and Gonzalo Acero, and Karen Manoutcharian, and David B Weiner, and Kenneth E Ugen, and Goar Gevorkian
January 2006, Sheng wu gong cheng xue bao = Chinese journal of biotechnology,
Victor Raul Gómez-Román, and Chuanhai Cao, and Yun Bai, and Hugo Santamaría, and Gonzalo Acero, and Karen Manoutcharian, and David B Weiner, and Kenneth E Ugen, and Goar Gevorkian
April 2000, DNA and cell biology,
Victor Raul Gómez-Román, and Chuanhai Cao, and Yun Bai, and Hugo Santamaría, and Gonzalo Acero, and Karen Manoutcharian, and David B Weiner, and Kenneth E Ugen, and Goar Gevorkian
January 2005, AIDS research and human retroviruses,
Victor Raul Gómez-Román, and Chuanhai Cao, and Yun Bai, and Hugo Santamaría, and Gonzalo Acero, and Karen Manoutcharian, and David B Weiner, and Kenneth E Ugen, and Goar Gevorkian
January 1996, Methods in enzymology,
Victor Raul Gómez-Román, and Chuanhai Cao, and Yun Bai, and Hugo Santamaría, and Gonzalo Acero, and Karen Manoutcharian, and David B Weiner, and Kenneth E Ugen, and Goar Gevorkian
January 1998, Biological chemistry,
Victor Raul Gómez-Román, and Chuanhai Cao, and Yun Bai, and Hugo Santamaría, and Gonzalo Acero, and Karen Manoutcharian, and David B Weiner, and Kenneth E Ugen, and Goar Gevorkian
April 2000, European journal of immunology,
Victor Raul Gómez-Román, and Chuanhai Cao, and Yun Bai, and Hugo Santamaría, and Gonzalo Acero, and Karen Manoutcharian, and David B Weiner, and Kenneth E Ugen, and Goar Gevorkian
June 2002, Ai zheng = Aizheng = Chinese journal of cancer,
Victor Raul Gómez-Román, and Chuanhai Cao, and Yun Bai, and Hugo Santamaría, and Gonzalo Acero, and Karen Manoutcharian, and David B Weiner, and Kenneth E Ugen, and Goar Gevorkian
January 1991, Journal of clinical laboratory analysis,
Victor Raul Gómez-Román, and Chuanhai Cao, and Yun Bai, and Hugo Santamaría, and Gonzalo Acero, and Karen Manoutcharian, and David B Weiner, and Kenneth E Ugen, and Goar Gevorkian
March 1993, Biochemical and biophysical research communications,
Victor Raul Gómez-Román, and Chuanhai Cao, and Yun Bai, and Hugo Santamaría, and Gonzalo Acero, and Karen Manoutcharian, and David B Weiner, and Kenneth E Ugen, and Goar Gevorkian
September 2011, Journal of immunological methods,
Copied contents to your clipboard!